| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5846654 | Toxicology and Applied Pharmacology | 2013 | 9 Pages |
Abstract
GSK-3 inhibition caused hADSC osteoblastogenesis and mineralisation in vitro. Increased femur bone mass associated with changes in bone turnover biomarkers confirmed in vivo bone formation and indicated uncoupling of bone formation and resorption.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Peter S. Gilmour, Patrick J. O'Shea, Malbinder Fagura, James E. Pilling, Hitesh Sanganee, Hiroki Wada, Paul F. Courtney, Stefan Kavanagh, Peter A. Hall, K. Jane Escott,